Hikma Pharmaceutical | HIK - Operating Expenses

Stock Price
1,266.00
Daily Change
26.00 2.10%
Monthly
-20.88%
Yearly
-37.64%
Q1 Forecast
1,214.21

Hikma Pharmaceutical reported $1.34B in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Almirall EUR 517.4M 32K Dec/2025
argenx SE USD 914.57M 137.58M Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Autolus Therapeutics Ltd USD 92.82M 10.21M Sep/2025
Bayer EUR 10.33B 126M Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Galapagos EUR 120.26M 7.43M Dec/2025
Genmab DKK 565M 38M Jun/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.71B 193M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.78B 669M Dec/2025
Orion EUR 367.1M 64.9M Dec/2025
Recordati EUR 384.01M 82.67M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
UCB EUR 2.36B 108M Dec/2024